JDRF's Focus Areas
JDRF has been part of every advancement in type 1 diabetes (T1D) care in the last 50 years. As the world’s largest funder of T1D research, we collaborate, connect and co-ordinate the world’s greatest minds to deliver tangible improvements for the T1D community.
Through our tireless representation of the challenges facing the T1D community we have, in partnership with our advocates, delivered real change. We have changed how Governments view type 1 diabetes and delivered nearly $500m in new investment in T1D in 10 years.
A community driven organisation founded to support Australians living with type 1 diabetes, the T1D community is our focus. From first diagnosis through to living with T1D as an adult, our resources, staff, and community are with you each step of the way.
Changing the world is challenging and expensive. People from a range of backgrounds have provided JDRF significant support, whether it is leaving a bequest or participating in events like the One Walk. These funds have been crucial for supporting research.
Get the latest updates from JDRF as we lead the fight against type 1 diabetes
The researchers changing the future of type 1 diabetes
JDRF-funded Professors Jenny Couper, Simon Barry and Toby Coates on their research projects and their hopes for the future of T1D.
JDRF's latest news
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
Fiasp insulin to remain on the Pharmaceutical Benefits Scheme
MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]
Type 1 diabetes and women’s health: periods and menopause
We all know how powerful hormones can be in controlling menstrual cycles, so it’s no surprise that they can also affect blood glucose levels. This can also make life a bit more challenging for women living with type 1 diabetes (T1D). In our book for adults living with T1D, Straight to the Point, we look […]
Support for siblings of children living with type 1 diabetes
If you have experience with type 1 diabetes (T1D), you’ll know that it can affect the whole family. And siblings of a child living with T1D can also be impacted by their brother or sister’s diagnosis. Although they’re not the ones being treated for T1D, siblings can be significantly impacted in lots of other ways. […]
Advocacy spotlight: Reece & Brittany Wilson
At the age of 24, Reece suffered a stroke, and his wife Brittany was diagnosed with an aggressive form of breast cancer. Just nine months into her treatment, Reece was diagnosed with type 1 diabetes (T1D). “For a person living with T1D, the outcome of a cure, recovery or even remission is not an option.” […]
New clinical trial looking for newly diagnosed children and young adults with T1D
In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC), investigating whether we can […]
JDRF’s Research Symposium: Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs
Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs On the 24th and 25th July 2023, JDRF Australia was delighted to host a research symposium: T1Decade of Research Progress – Past & Future to commemorate over a decade of achievements of the Type 1 Diabetes Clinical Research Network (T1DCRN). The T1DCRN is […]
2023 JDRF Australia PhD scholarships announced
JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute. The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to […]
JDRF Australia and Cicada Innovations partner to progress research breakthroughs
JDRF Australia is excited to announce our partnership with Cicada Innovations, leaders in deep tech incubation to accelerate scientific progress and bridge translation gaps. Our partnership will accelerate type 1 diabetes (T1D) research translation and commercialisation through providing resources, mentorship, funding, and networking opportunities. Our goal is to bring scientific discoveries into real-world solutions for […]